Rangeley Capital, LLC
- SEC CIK
- 0001517796
- Latest filing
- Aug 14, 2026
KROS holding history
Keros Therapeutics, Inc. in every 13F filed by Rangeley Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KROS overviewAll 13F holders of KROSFull Q2 2026 holdings
- Shares (Q2 2026)
- 54,400
- Value
- $582.1K
- % of portfolio
- 0.6%
- Quarters held
- 6
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 54,400 | $582.1K | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2026 | 54,400 | $600.6K | 0.6% | −42,400−43.8% | Reduced | Holders |
| Q4 2025 | 96,800 | $1.97M | 1.7% | −161,819−62.6% | Reduced | Holders |
| Q3 2025 | 258,619 | $4.09M | 3.8% | −26,781−9.4% | Reduced | Holders |
| Q2 2025 | 285,400 | $3.81M | 4.8% | −122,834−30.1% | Reduced | Holders |
| Q1 2025 | 408,234 | $4.16M | 4.8% | +408,234 | New | Holders |